STC BIOLOGICS, INC

Basic Information

763 D Concord Ave
CAMBRIDGE, MA, 02138

http://www.stcbiologics.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 829731814
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y
Number of Employees: 7


  1. A Multi-Targeting Ligand Trap to Overcome resistance in BRAF Mutant Colorectal Cancer

    Amount: $300,000.00

    DESCRIPTION provided by applicant Although targeted therapies have been developed to treat cancers with well elucidated molecular pathways these therapies still remain ineffective as innate or ac ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of HealthDepartment of Health and Human Services
  2. IGF::OT::IGF SBIR PHASE II TOPIC 275, DEVELOPMENT OF GENERIC TRASTUZUMAB FOR THE TREATMENT OF BREAST CANCER.

    Amount: $2,499,488.00

    The goal of this project is to develop STC101, a biosmilar Herceptin . Trastuzumab is a monoclonal antibody made against the HER2 protein that is overexpressed in 20-25% of patients with breast cancer ...

    SBIR Phase II 2012 Department of Health and Human Services
  3. Not Available

    Amount: $299,881.00

    The goal of this project is to develop STC trastuzumab, a generic version of Herceptin. Trastuzumab is a monoclonal antibody made against the HER2 protein that is overexpressed in 20-25% of patients w ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government